Candriam S.C.A. Guardant Health, Inc. Transaction History

Candriam S.C.A.

$16.8 Billion
Q2 2025

A detailed history of Candriam S.C.A. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 170,522 shares of GH stock, worth $12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

170,522

Previous 172,874 1.36%

Holding current value

$12 Million

Previous $7.36 Million 20.49%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$37.05 - $52.04 $87,141 - $122,398	-2,352 Reduced 1.36%	170,522 $8.87 Million
Q1 2025 May 14, 2025	SELL	$31.77 - $49.94 $5.71 Million - $8.97 Million	-179,618 Reduced 50.96%	172,874 $7.36 Million
Q4 2024 Feb 06, 2025	SELL	$20.2 - $38.11 $275,790 - $520,315	-13,653 Reduced 3.73%	352,492 $10.8 Million
Q2 2024 Aug 05, 2024	SELL	$16.07 - $31.84 $1.61 Million - $3.18 Million	-99,992 Reduced 21.45%	366,145 $10.6 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $539,500 - $737,500	-25,000 Reduced 5.09%	466,137 $12.6 Million
Q3 2023 Nov 13, 2023	SELL	$25.8 - $39.97 $1.76 Million - $2.73 Million	-68,225 Reduced 12.2%	491,137 $14.6 Million
Q2 2023 Aug 08, 2023	BUY	$20.94 - $38.01 $799,489 - $1.45 Million	38,180 Added 7.33%	559,362 $20 Million
Q1 2023 May 12, 2023	BUY	$22.92 - $33.76 $1.41 Million - $2.08 Million	61,538 Added 13.39%	521,182 $12.2 Million
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $6.88 Million - $16.2 Million	270,594 Added 143.13%	459,644 $12.5 Million
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $1.72 Million - $2.41 Million	39,469 Added 26.39%	189,050 $10.2 Million
Q2 2022 Aug 03, 2022	BUY	$28.82 - $77.35 $288,200 - $773,500	10,000 Added 7.16%	149,581 $6.03 Million
Q1 2022 May 13, 2022	SELL	$48.25 - $100.49 $371,911 - $774,576	-7,708 Reduced 5.23%	139,581 $9.25 Million
Q4 2021 Feb 10, 2022	BUY	$88.71 - $120.43 $2.03 Million - $2.76 Million	22,917 Added 18.43%	147,289 $14.7 Million
Q3 2021 Nov 09, 2021	BUY	$98.77 - $132.17 $2.63 Million - $3.53 Million	26,676 Added 27.31%	124,372 $15.5 Million
Q2 2021 Jul 20, 2021	BUY	$109.77 - $165.68 $1.03 Million - $1.55 Million	9,344 Added 10.58%	97,696 $12.1 Million
Q4 2020 Jan 22, 2021	SELL	$99.96 - $135.93 $398,440 - $541,816	-3,986 Reduced 4.32%	88,352 $11.4 Million
Q3 2020 Oct 19, 2020	BUY	$80.32 - $111.8 $1.1 Million - $1.54 Million	13,751 Added 17.5%	92,338 $10.3 Million
Q2 2020 Jul 23, 2020	BUY	$60.49 - $97.5 $1.26 Million - $2.03 Million	20,829 Added 36.06%	78,587 $6.38 Million
Q1 2020 May 26, 2020	BUY	$59.04 - $88.81 $354 - $532	6 Added 0.01%	57,758 $4.41 Million
Q4 2019 Jan 21, 2020	BUY	$59.49 - $82.78 $2.83 Million - $3.94 Million	47,552 Added 466.2%	57,752 $5,000
Q3 2019 Oct 21, 2019	SELL	$62.59 - $110.3 $287,288 - $506,277	-4,590 Reduced 31.03%	10,200 $1,000
Q2 2019 Aug 01, 2019	BUY	$63.94 - $91.11 $549,244 - $782,634	8,590 Added 138.55%	14,790 $5.49 Million
Q1 2019 May 02, 2019	BUY	$34.3 - $97.98 $212,659 - $607,476	6,200 New	6,200 $476,000

Others Institutions Holding GH

# of Institutions

421

Shares Held

125M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $7.18B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account